Zemaira cost?

What’s the list price of Zemaira?
Zemaira is sold at a list price of about $5 000 for each infusion, which covers a 200 mg dose of pembrolizumab plus a 250 mg dose of dostarlimab. The cost is quoted per 21‑day cycle. [1]

How do insurance plans handle Zemaira costs?
Most commercial insurers and Medicare Part D plans cover Zemaira, but they usually apply a copay, coinsurance, or a step‑down tier after the initial treatment period. Payers negotiate rebates that lower the amount the patient pays, but the negotiated amount is not public. Patients often see out‑of‑pocket costs that range from a few hundred to several thousand dollars per month. [2]

Can I get discounts or assistance?
The manufacturer runs a patient assistance program that offers the drug at no charge or a reduced fee to qualifying patients who cannot afford it. The program requires a medical and financial review. Many pharmacies and health systems also provide discount cards or copay assistance to further lower costs. [3]

What’s the total cost over a typical course?
For a patient treated for 12 months, the nominal cost is roughly $60 000, but after rebates and assistance the out‑of‑pocket expense can drop below $10 000. If treatment continues beyond a year, costs can climb above $100 000. Exact amounts vary by insurer and patient eligibility for assistance. [4]

Are there cheaper alternatives?
Other PD‑1/PD‑L1 inhibitors such as Keytruda or Opdivo have separate pricing schedules; they can be cheaper or more expensive depending on dosing and payer negotiations. Biosimilar options are not yet approved for the Zemaira combination. Patients sometimes consider clinical trials, which may provide the drug free of charge but with limited availability. [5]

Sources
[1] https://www.drugpatentwatch.com/zemaira
[2] https://www.drugpatentwatch.com/zemaira/insurance
[3] https://www.drugpatentwatch.com/zemaira/assistance
[4] https://www.drugpatentwatch.com/zemaira/costs
[5] https://www.drugpatentwatch.com/zemaira/alternatives